| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Chief Financial Officer | ADSs | 80.5K | $1.17M | $14.50 | Jan 16, 2024 | Direct |
| AVADEL PHARMACEUTICALS PLC | Chief Financial Officer | Stock Option (Right to Buy) | 158K | Feb 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AVDL | AVADEL PHARMACEUTICALS PLC | Feb 20, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Chief Financial Officer |
| AVDL | AVADEL PHARMACEUTICALS PLC | Jan 16, 2024 | 1 | $29K | 4 | Jan 16, 2024 | Chief Financial Officer |
| AVDL | AVADEL PHARMACEUTICALS PLC | Aug 14, 2023 | 1 | $28.9K | 4 | Aug 14, 2023 | Chief Financial Officer |
| AVDL | AVADEL PHARMACEUTICALS PLC | Jun 5, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Chief Financial Officer |
| AVDL | AVADEL PHARMACEUTICALS PLC | Nov 29, 2022 | 1 | $39K | 4 | Nov 30, 2022 | Chief Financial Officer |
| AVDL | AVADEL PHARMACEUTICALS PLC | May 27, 2022 | 1 | $107K | 4 | May 31, 2022 | Chief Financial Officer |
| AVDL | AVADEL PHARMACEUTICALS PLC | Dec 7, 2021 | 1 | $0 | 4 | Dec 9, 2021 | Chief Financial Officer |